Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clin

VANCOUVER, British Columbia, May 28, 2024 -- Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azetukalner clinical data in...

Related Keywords

Canada , United States , Vancouver , British Columbia , Miami , Florida , United Kingdom , Canadian , American , British , Jodi Regts , Joe Mcintosh , Ian Mortimer , Exchange Commission , Clinical Development , Securities Exchange , American Society Of Clinical Psychopharmacology , Xenon Pharmaceuticals Inc , Xenon Corporate Affairs , Nasdaq , Xenon Pharmaceuticals Nasdaq , Xenon Pharmaceuticals , American Society , Clinical Psychopharmacology , Chief Executive Officer , Channel Opener , Adults With Moderate , Severe Major Depressive Disorder , Results From , Senior Vice President , Efficacy Data , Depression Rating Scale , Hamilton Depression Rating Scale , Snaith Hamilton Pleasure Scale , Clinical Global Impression , Tolerability Data , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,